Androgen insensitivity syndrome epidemiology and demographics
Androgen insensitivity syndrome Microchapters |
Differentiating Androgen insensitivity syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Androgen insensitivity syndrome epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Androgen insensitivity syndrome epidemiology and demographics |
FDA on Androgen insensitivity syndrome epidemiology and demographics |
CDC on Androgen insensitivity syndrome epidemiology and demographics |
Androgen insensitivity syndrome epidemiology and demographics in the news |
Blogs on Androgen insensitivity syndrome epidemiology and demographics |
Directions to Hospitals Treating Androgen insensitivity syndrome |
Risk calculators and risk factors for Androgen insensitivity syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographic
Prevalence
- CAIS has aprevalence of 2 per100,000 to 5 per100,000 in otherwise healthy phenotypic females who had histologically normal inguinal or abdominal testes.
- PAIS is at least as common as CAIS.
- MAIS is much less frequently reported than CAIS and PAIS.
Incidence
- The incidence of complete AIS is about in 5 in 100,000. The incidence of milder degrees of androgen resistance might be both more common or less common than CAIS. Evidence suggests many cases of unexplained male infertility may be due to the mildest forms of androgen resistance.
- In netherlands, the minimal incidence was 1 per 99,000 over a ten-year period.